ImmuPharma PLC (IMM) — Financial Flexibility Index
ImmuPharma PLC (IMM) has a Financial Flexibility Index of -0.81x as of June 2025. Free cash flow of GBX-1.00 Million (operating CF GBX-1.00 Million minus capex GBX0.00) represents -1% of total liabilities (GBX1.24 Million). Also explore net asset momentum of ImmuPharma PLC to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ImmuPharma PLC Financial Flexibility Index (2004–2024)
Historical Financial Flexibility Index trend for ImmuPharma PLC across 21 annual periods. Check ImmuPharma PLC PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for ImmuPharma PLC (2004–2024)
Year-by-year free cash flow to debt coverage for ImmuPharma PLC. For the full company profile including market capitalisation, see how much is ImmuPharma PLC worth.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.16x | GBX-1.77 Million | GBX-1.77 Million | GBX1.52 Million | ▼ -41.9% |
| 2023 | -0.82x | GBX-1.36 Million | GBX-1.36 Million | GBX1.67 Million | ▲ +46.9% |
| 2022 | -1.54x | GBX-2.24 Million | GBX-2.35 Million | GBX1.45 Million | ▲ +48.8% |
| 2021 | -3.02x | GBX-4.78 Million | GBX-4.83 Million | GBX1.58 Million | ▼ -28.2% |
| 2020 | -2.35x | GBX-2.97 Million | GBX-3.33 Million | GBX1.26 Million | ▲ +69.6% |
| 2019 | -7.74x | GBX-4.11 Million | GBX-4.22 Million | GBX531.87K | ▼ -73.3% |
| 2018 | -4.46x | GBX-4.62 Million | GBX-4.72 Million | GBX1.03 Million | ▼ -46.5% |
| 2017 | -3.05x | GBX-4.40 Million | GBX-4.42 Million | GBX1.44 Million | ▲ +45.3% |
| 2016 | -5.57x | GBX-6.48 Million | GBX-6.49 Million | GBX1.16 Million | ▼ -105.4% |
| 2015 | -2.71x | GBX-4.13 Million | GBX-4.15 Million | GBX1.52 Million | ▼ -72.9% |
| 2014 | -1.57x | GBX-2.14 Million | GBX-2.49 Million | GBX1.37 Million | ▲ +27.8% |
| 2013 | -2.17x | GBX-3.91 Million | GBX-3.91 Million | GBX1.80 Million | ▼ -39.9% |
| 2012 | -1.55x | GBX-3.24 Million | GBX-3.26 Million | GBX2.09 Million | ▲ +16.7% |
| 2011 | -1.86x | GBX-3.30 Million | GBX-3.37 Million | GBX1.77 Million | ▲ +56.5% |
| 2010 | -4.28x | GBX-6.77 Million | GBX-6.84 Million | GBX1.58 Million | ▼ -334.4% |
| 2009 | 1.82x | GBX11.97 Million | GBX11.96 Million | GBX6.56 Million | ▲ +253.6% |
| 2008 | -1.19x | GBX-2.57 Million | GBX-2.57 Million | GBX2.16 Million | ▲ +65.6% |
| 2007 | -3.45x | GBX-3.62 Million | GBX-3.63 Million | GBX1.05 Million | ▼ -638.1% |
| 2006 | -0.47x | GBX-525.00K | GBX-879.00K | GBX1.12 Million | ▼ -124.2% |
| 2005 | 1.93x | GBX27.00K | GBX27.00K | GBX14.00K | ▲ +285.7% |
| 2004 | 0.50x | GBX1.00K | GBX1.00K | GBX2.00K | — |